COSM NASDAQ
Cosmos Health Inc.
1W: +8.1%
1M: +69.4%
3M: +40.8%
YTD: -26.2%
1Y: -65.5%
3Y: -77.0%
5Y: -92.0%
$0.38
-0.01 (-1.58%)
Weekly Expected Move ±14.9%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-05-11
Earliest Filing
2025-01-22
Latest Filing
target: 2
licensee: 1
Counterparties (Filed by COSM)
3 relationshipsCompanies named in COSM's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| DocPharma Single SA. | — | licensee | Granted Cosmos Health Inc. a royalty-bearing, exclusive worldwide license to commercialize patents for cancer treatment. | 2025-01-22 | View |
| Cana Holdings | CNQ | target | Target of stock purchase agreement and recipient of promissory note | 2023-05-11 | View |
| Cana Pharma | — | target | Wholly-owned subsidiary of Cana Holdings whose stock secures the promissory note | 2023-05-11 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-20 | Earnings Release; Exhibits | View | |
| 2026-07-16 | Officer/Director Change; Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-07-06 | Regulation FD; Other Events; Exhibits | View | |
| 2026-05-22 | Earnings Release; Exhibits | View | |
| 2026-04-16 | Earnings Release; Exhibits | View | |
| 2025-12-18 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-11-17 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-10-17 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-06 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-10-01 | Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or | View | |
| 2025-09-29 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-08-11 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-08-06 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-05-07 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-02-18 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-01-29 | Creation of Direct Financial Obligation; Financial Statements and Exhibits | View | |
| 2025-01-22 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-11-21 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-11-12 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2024-09-27 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR